Contact
Please use this form to send email to PR contact of this press release:
Rosen, a Leading Law Firm, Announces Filing of Securities Class Action Lawsuit Against Karyopharm Therapeutics Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm – KPTI
TO: